AdventHealthMD
A recent study, called FLOW, showed Ozempic had dramatic results in slowing chronic kidney disease progression in participants with Type 2 diabetes.
AdventHealth physicians Dr. Christopher Dobson and Dr. Rajendra Sawh-Martinez recently returned from a medical mission trip abroad, donating their time to travel to improve the lives of kids with...
A new clinical research study, conducted in partnership between CytoVeris Inc. and AdventHealth in Central Florida, will investigate the precision of using an AI-powered imaging device during surgery...
As the health care community evolves from pandemic to endemic, many hospitals are realizing the need for multidisciplinary COVID-19 clinics, like the AdventHealth model. AdventHealth physicians share...
As AdventHealth Central Florida Division Chief Clinical Officer, Neil Finkler, M.D., prepares to retire he reflects on his three decades with AdventHealth, the highlights of how he saw medicine change...
The AdventHealth Central Florida Division recently hosted the Florida Medical Association for a tour of the nation’s largest hospital system command center called Mission Control, which will be...
Our website uses cookies. Please review our privacy policy to find out more about the cookies we use. Browsing our website means you accept these terms.